Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
arts and humanities
Orbitofacial neurofibromatosis: Clinical characteristics and treatment outcome
Eye, Volume 26, No. 4, Year 2012
Notification
URL copied to clipboard!
Description
Purpose To report clinical observations and surgical management in a large series of patients with orbitofacial neurofibromatosis type 1 (OFNF). Patients and methods Patients were identified and medical records reviewed for demographic data, ophthalmologic examinations, surgical interventions, and procedure outcome to create a retrospective, non-comparative case series of patients with OFNF seen at one medical centre over a 23-year period. Results Sixty patients with OFNF (31 females and 29 males; mean age, 14 years) were followed for an average of 5.7 years. Presenting signs and symptoms included eyelid swelling in all patients, ptosis in 56 (93.3%), proptosis in 34 (56.6%), dystopia or strabismus in 30 (50%), and decreased visual acuity in 50 (83.3%). Surgical intervention included ptosis repair in 54 (90%; mean 1.6 surgical procedures), facial and orbital tumour debulking in 54 (90%; mean 2.3 surgeries), and canthoplasty in 28 (46.6%) patients. Eleven patients required enucleation or exenteration of a blind eye. Conclusion Patients with OFNF often require multiple procedures to preserve vision, prevent additional disfigurement, and achieve cosmetic rehabilitation. Patients need regular ophthalmological monitoring given the potential for progressive visual and cosmetic consequences. © 2012 Macmillan Publishers Limited All rights reserved.
Authors & Co-Authors
Chaudhry, Imtiaz
Saudi Arabia, Riyadh
King Khaled Eye Specialist Hospital
Morales, Jose
Saudi Arabia, Riyadh
King Khaled Eye Specialist Hospital
Shamsi, Farrukh A.
Saudi Arabia, Riyadh
King Khaled Eye Specialist Hospital
Al-Rashed, W.
Saudi Arabia, Riyadh
King Khaled Eye Specialist Hospital
Elzaridi, E.
Saudi Arabia, Riyadh
King Khaled Eye Specialist Hospital
Arat, Y. O.
United States, Madison
University of Wisconsin-madison
Jacquemin, Claude
Saudi Arabia, Riyadh
King Khaled Eye Specialist Hospital
Oystreck, Darren T.
Saudi Arabia, Riyadh
College of Medicine
Bosley, Thomas M.
Saudi Arabia, Riyadh
King Khaled Eye Specialist Hospital
Saudi Arabia, Riyadh
College of Medicine
Statistics
Citations: 35
Authors: 9
Affiliations: 3
Identifiers
Doi:
10.1038/eye.2011.336
ISSN:
0950222X
e-ISSN:
14765454
Research Areas
Cancer
Disability
Health System And Policy
Study Design
Randomised Control Trial
Cohort Study
Participants Gender
Female